Your browser is no longer supported. Please, upgrade your browser.
BLU [NASD]
BELLUS Health Inc.
Index- P/E- EPS (ttm)-0.53 Insider Own3.30% Shs Outstand65.52M Perf Week-6.10%
Market Cap298.14M Forward P/E- EPS next Y-0.79 Insider Trans0.00% Shs Float61.15M Perf Month-10.26%
Income-31.80M PEG- EPS next Q-0.14 Inst Own65.61% Short Float4.74% Perf Quarter4.34%
Sales0.01M P/S19876.27 EPS this Y1.90% Inst Trans-0.03% Short Ratio2.42 Perf Half Y65.24%
Book/sh2.25 P/B1.71 EPS next Y- ROA-23.80% Target Price- Perf Year-62.48%
Cash/sh1.27 P/C3.04 EPS next 5Y- ROE-24.90% 52W Range2.01 - 12.03 Perf YTD25.82%
Dividend- P/FCF- EPS past 5Y- ROI- 52W High-68.00% Beta0.24
Dividend %- Quick Ratio18.10 Sales past 5Y- Gross Margin- 52W Low91.54% ATR0.23
Employees32 Current Ratio18.10 Sales Q/Q-42.90% Oper. Margin- RSI (14)40.65 Volatility5.34% 5.81%
OptionableYes Debt/Eq0.00 EPS Q/Q78.00% Profit Margin- Rel Volume0.14 Prev Close3.75
ShortableYes LT Debt/Eq0.00 Earnings- Payout- Avg Volume1.20M Price3.85
Recom- SMA20-9.83% SMA50-6.35% SMA20021.38% Volume170,513 Change2.67%
Jan-29-21Initiated RBC Capital Mkts Outperform $8
Nov-18-20Initiated Evercore ISI Outperform $12
Jul-07-20Downgrade Guggenheim Buy → Neutral
Jun-26-20Initiated H.C. Wainwright Buy $28
Sep-30-19Initiated Jefferies Buy $20
Sep-30-19Initiated Guggenheim Buy $12
Sep-30-19Initiated Cowen Outperform
May-07-21 02:30PM  
02:05PM  
May-06-21 11:45AM  
11:00AM  
06:30AM  
May-05-21 10:38PM  
10:01PM  
10:45AM  
10:14AM  
May-04-21 11:30AM  
11:00AM  
11:00AM  
May-03-21 04:51PM  
03:12PM  
12:35PM  
12:00PM  
06:30AM  
May-02-21 11:52PM  
Apr-30-21 09:22PM  
10:35AM  
10:00AM  
Apr-29-21 06:10PM  
05:22PM  
12:45PM  
12:00PM  
10:25AM  
09:23AM  
06:30AM  
Apr-28-21 09:00PM  
03:30PM  
03:00PM  
11:25AM  
11:00AM  
Apr-27-21 06:05PM  
05:38PM  
04:24PM  
03:02PM  
10:30AM  
10:00AM  
10:00AM  
06:30AM  
Apr-26-21 10:10PM  
12:00PM  
11:00AM  
06:30AM  
Apr-24-21 07:50PM  
01:47AM  
Apr-23-21 11:11PM  
09:00PM  
Apr-22-21 09:30AM  
09:07AM  
07:19AM  
06:30AM  
Apr-21-21 10:45PM  
05:30PM  
05:00PM  
03:45PM  
03:11PM  
02:00PM  
12:28PM  
11:00AM  
Apr-20-21 10:51AM  
Apr-19-21 08:48PM  
08:00PM  
01:22PM  
12:23PM  
11:40AM  
11:00AM  
06:30AM  
Apr-17-21 01:19PM  
Apr-16-21 11:05PM  
01:35PM  
01:00PM  
12:15PM  
11:45AM  
Apr-15-21 02:40PM  
02:19PM  
11:30AM  
11:00AM  
Apr-14-21 06:34PM  
06:00PM  
Apr-13-21 02:39PM  
01:02PM  
12:00PM  
11:35AM  
11:00AM  
11:00AM  
10:20AM  
09:19AM  
07:00AM  
Apr-12-21 09:30PM  
08:02PM  
01:25PM  
01:12PM  
01:00PM  
06:30AM  
Apr-10-21 05:45PM  
Apr-09-21 01:07PM  
11:40AM  
10:30AM  
BELLUS Health Inc., a clinical stage biopharmaceutical company, develops therapeutics for the treatment of chronic cough and other hypersensitization disorders. Its lead drug candidate includes BLU-5937, an oral small molecule antagonist of the P2X3 receptor, which is in Phase II clinical trial for treatment of chronic cough and chronic pruritus. The company was founded in 1993 and is headquartered in Laval, Canada.